IntegraDose Compounding Services LLC

FDA recalling firm · 7 enforcement events · 8 product records · 2021–2026 · MN

IntegraDose Compounding Services LLC has 7 FDA enforcement events on this register (8 product records) between 2021 and 2026: 7 drug; the busiest year was 2024 with 3.

14% of its events are Class I; the most common class is Class II (6). 6 events are listed as ongoing; the recalling firm's address is in MN.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

Initiated	Product (first record)	Type	Class	Records	Status
18 May 2026	Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.	Drug	Class II	1	Ongoing
12 May 2026	fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.	Drug	Class II	1	Ongoing
16 Sep 2025	Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1	Drug	Class I	1	Ongoing
22 Mar 2024	fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1	Drug	Class II	1	Ongoing
22 Jan 2024	Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.	Drug	Class II	1	Ongoing
12 Jan 2024	Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1	Drug	Class II	1	Ongoing
17 Sep 2021	ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1	Drug	Class II	2	Terminated

By type and class

Drug7

Class II6

Class I1

Class I: 14% of this firm's events; 18% of all events on the register.

Events by year

Enforcement events for IntegraDose Compounding Services LLC by year initiated.

Questions and answers

How many FDA recalls has IntegraDose Compounding Services LLC had?

7 enforcement events (8 product records) on this register, 2021–2026: 7 drug.

Are any IntegraDose Compounding Services LLC recalls ongoing?

6 events are listed as ongoing in the current openFDA export.

What class are IntegraDose Compounding Services LLC recalls?

6 Class II, 1 Class I. 14% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.